Zynex Inc. logo

Zynex Inc. (ZYXI)

Market Closed
12 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
0. 74
-0.12
-14.38%
$
38.29M Market Cap
47.57 P/E Ratio
0% Div Yield
779,692 Volume
0.51 Eps
$ 0.86
Previous Close
Day Range
0.74 0.88
Year Range
0.38 8.72
Want to track ZYXI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 74 days

Summary

ZYXI closed yesterday lower at $0.74, a decrease of 14.38% from Thursday's close, completing a monthly decrease of -42.75% or $0.55. Over the past 12 months, ZYXI stock lost -90.91%.
ZYXI pays dividends to its shareholders, with the most recent payment made on Jan 21, 2022. The next estimated payment will be in 21 Jan 2022 on Jan 21, 2022 for a total of $0.09091.
The last earnings report, released on Nov 20, 2025, exceeded the consensus estimates by 0.19%. On average, the company has fell short of earnings expectations by -0.29%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
Zynex Inc. has completed 1 stock splits, with the recent split occurring on Jan 05, 2022.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

ZYXI Chart

Similar

Farmer Brothers Company
$ 1.51
-3.82%
Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript

Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript

Zynex, Inc. ( ZYXI ) Q3 2025 Earnings Call November 18, 2025 9:00 AM EST Company Participants Vikram Bajaj - Chief Financial Officer Steven Dyson - CEO & Director Presentation Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Zynex Third Quarter 2025 Earnings Conference Call.

Seekingalpha | 3 weeks ago
Zynex taps adviser Province, forms special board committee to review strategic options

Zynex taps adviser Province, forms special board committee to review strategic options

Zynex Inc (NASDAQ:ZYXI) said on Friday it has hired financial advisory firm Province LLC and formed a special board committee to evaluate a range of strategic alternatives. The company said Province will assist in reviewing options that include potential capital-raising, recapitalization and restructuring strategies.

Proactiveinvestors | 1 month ago
Zynex welcomes Steve Dyson as CEO, adds to leadership team

Zynex welcomes Steve Dyson as CEO, adds to leadership team

Zynex Inc (NASDAQ:ZYXI), a medical technology company specializing in non-invasive devices for pain management, rehabilitation, and patient monitoring, announced the arrival of Steven Dyson as its new CEO, along with the appointment of several senior leaders. The company announced back in June that Dyson had been selected as incoming CEO.

Proactiveinvestors | 3 months ago

Zynex Inc. (ZYXI) FAQ

What is the stock price today?

The current price is $0.74.

On which exchange is it traded?

Zynex Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is ZYXI.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 38.29M.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Zynex Inc. ever had a stock split?

Zynex Inc. had 1 splits and the recent split was on Jan 05, 2022.

Zynex Inc. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Steven Lewis Dyson CEO
NASDAQ (NGS) Exchange
98986M103 CUSIP
US Country
1,000 Employees
21 Jan 2022 Last Dividend
5 Jan 2022 Last Split
31 Dec 2002 IPO Date

Overview

Zynex, Inc., established in 1996 and headquartered in Englewood, Colorado, is a prominent company that specializes in designing, manufacturing, and marketing innovative medical devices aimed at treating chronic and acute pain, as well as facilitating muscle rehabilitation. Through its subsidiaries, Zynex has developed a reputation for creating devices that use electrical stimulation to aid in pain management and muscle activation. The company’s commitment to improving patient outcomes is evident through its diverse product portfolio, which caters to a wide range of medical needs, including pain management, stroke and spinal cord injury rehabilitation, and hemodynamic monitoring. Zynex's approach to the market involves direct sales primarily in the United States, utilizing a team of dedicated field sales representatives to engage with physicians and therapists.

Products and Services

  • NexWave: This dual channel, multi-modality device provides interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES), marketed primarily to physicians and therapists. NexWave is aimed at the treatment of various pain conditions and muscle rehabilitation.
  • NeuroMove: Focused on aiding stroke and spinal cord injury recovery, the NeuroMove is an electromyography triggered electrical stimulation device designed to encourage neuromuscular reeducation and function restoration.
  • InWave: Developed for the treatment of female urinary incontinence, the InWave product utilizes electrical stimulation to strengthen pelvic floor muscles, thereby addressing this widespread condition.
  • E-Wave: This NMES device targets muscle activation and exercise, promoting the rehabilitation and strengthening of muscles through controlled electrical stimulation.
  • Private Labeled Products: Zynex also offers a range of private labeled products, including electrodes for electrical current delivery to the body and batteries for electrotherapy devices, enhancing the effectiveness and usability of its solutions.
  • Comfortrac/Saunders: Distributed by Zynex, these products offer cervical traction solutions designed to alleviate neck pain and improve spinal health.
  • JetStream: This product provides hot/cold therapy for pain relief and muscle recovery, catering to a variety of therapeutic needs.
  • LSO Back Braces: For lumbar support, the LSO Back Braces are designed to assist with lower back pain management and posture improvement.
  • Knee Braces: Aimed at knee support, these braces offer stability and relief for individuals with knee-related conditions or injuries.
  • Zynex Fluid Monitoring System (CM-1500): A non-invasive medical device for monitoring relative fluid volume changes in operating and recovery rooms, crucial for detecting fluid loss during surgery and internal bleeding during recovery.
  • Zynex Wireless Fluid Monitoring System (CM-1600): This advanced, noninvasive monitoring device measures relative changes in fluid volume in adult patients, enhancing patient care and monitoring capabilities.
  • NiCO CO-Oximeter and HemeOx tHb Oximeter: These laser-based, noninvasive devices provide critical measurement of blood oxygenation and total hemoglobin levels, supporting comprehensive hemodynamic monitoring during medical care.

Contact Information

Address: 9655 Maroon Circle
Phone: 303 703 4906